Longevity heavyweights and A-listers pack program for tenth annual Aging Research and Drug Discovery conference.
The largest conference on aging in the biopharmaceutical industry is set to take place 28 August – 1 September 2023 on-site in Copenhagen and online.
Longevity.Technology: The United Nations report that the proportion of people aged over 65 now outnumber children younger than 5. This substantial surge in the elderly populace presents a formidable healthcare challenge for societies across the globe, and it is evident that comprehensive and transformative approaches aimed at mitigating age-related illnesses and vulnerabilities will play a pivotal role in addressing the health and socioeconomic obstacles associated with an aging society. Once again this year, ARDD – now in its tenth year – is set to feature some of the most foremost experts in longevity, who will impart their latest insights on the process of aging and how we target the aging process to maximise lifespan and healthspan.
At ARDD, leaders in the aging and longevity field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions, making it one of the must-attend events in the longevity space.
The conference will be chaired by Morten Scheibye-Knudsen and Daniela Bakula of The University of Copenhagen and Insilico’s Alex Zhavoronkov, and, as the Ukrainian crisis is still ongoing, just as it did last year, ARDD is offering scientists from Ukraine free places at the conference.
One of this year’s highlights is certain to be the Emerging Tech Workshop on the Monday. The Workshop will explore the harmonic interplay between technologies that are transforming the future of biotechnology, drug discovery and aging research, and features a ‘hands-on journey’ through the realms of blockchain, AI and rapid prototyping with robotics in which participants will take their first guided steps into the metaverse. The Workshop will also explore how blockchain technology enables funding of high-risk biotech research and the role of community owned IP in the future of drug development, as well as demonstrating the power of AI and robotics to accelerate, enhance and scale scientific experiments.
The impressive line-up already boasts more than 70 speakers – too many to name, but the list includes Katrin Andreasson, Nir Barzilai, Joe Betts-LaCroix, Collin Ewald, Richard Faragher, Peter Fedichev, Kristen Fortney, Vadim Gladyshev, Brian Kennedy, James Kirkland, Morten Scheibye-Knudsen, Valter Longo, Andrea Maier, Joan Mannick, Laura Niedernhofer, Marco Quarta, Thomas Rando, Björn Schumacher, Vittorio Sebastiano, David Sinclair, Emma Teeling, Tzipora Strauss, Eric Verdin, Tony Wyss-Coray, Alex Zhavoronkov and Garri Zmudze.
ARDD 2023 is shaping up to be one of this year’s most significant longevity gatherings; as Zhavoronkov tweeted: “If you are thinking about how to engage in aging research in the most credible way possible – go to ARDD.”
We’ll be chatting to Alex Zhavoronkov and Morten Scheibye-Knudsen later in the week to find out more about what’s coming up at ARDD 2023 – stay tuned!